1167 — Jacobio Pharmaceuticals Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$3.34bn
- HK$2.22bn
- CNY155.71m
Annual cashflow statement for Jacobio Pharmaceuticals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1,514 | -301 | -372 | -359 | -156 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1,743 | 19 | -84.9 | -34.3 | -30.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -159 | 124 | 151 | 4.09 | 85.2 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 78.8 | -147 | -292 | -364 | -74.1 |
| Capital Expenditures | -11 | -11.1 | -16.5 | -38.7 | -12.1 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -205 | 173 | -670 | -8.72 | 268 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -216 | 162 | -686 | -47.4 | 256 |
| Financing Cash Flow Items | 180 | -0.513 | -3.4 | 52.1 | 38.4 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,275 | 109 | -9.85 | 246 | 21.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,116 | 96.8 | -903 | -155 | 208 |